NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CORCEPT THERAPEUTICS INC Logo
Develops and commercializes cortisol-modulating medications for severe disorders.
United States of America
CORT
Corline Biomedical AB Logo
Develops heparin-based solutions for medical devices and regenerative medicine.
Sweden
CLBIO
CorMedix Inc. Logo
Biopharma firm developing therapeutics for infectious and inflammatory diseases.
United States of America
CRMD
Corvus Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing therapies for immune diseases and cancer.
United States of America
CRVS
Cosma Spolka Akcyjna Logo
Manufactures and distributes hemp and cannabis products for humans and animals.
Poland
COS
COSMO Pharmaceuticals N.V. Logo
A specialty pharmaceutical firm focused on gastroenterology, dermatology, and healthtech.
Netherlands
COPN
Cosmos Health Inc. Logo
Vertically integrated healthcare group in the nutraceutical and pharmaceutical sectors.
United States of America
COSM
Coya Therapeutics, Inc. Logo
Clinical-stage biotech developing therapies to enhance regulatory T cell function.
United States of America
COYA
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. Logo
Clinical-stage biotech firm focused on regenerative medicine and immunotherapy.
United States of America
CELZ
CRESCENT BIOPHARMA, INC. Logo
Biopharmaceutical company researching and developing a pipeline of cancer therapies.
United States of America
CBIO

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.